[1] Anwanwan D, Singh SK, Singh S, et al.Challenges in liver cancer and possible treatment approaches[J].Biochim et Biophys Acta BBA-Rev Cancer, 2020, 1873(1):188314. [2] Buscail E, Alix-Panabières C, Quincy P, et al.High clinical value of liquid biopsy to detect circulating tumor cells and tumor exosomes in pancreatic ductal adenocarcinoma patients eligible for up-front surgery[J].Cancers, 2019, 11(11):1656. [3] von Felden J, Schulze K, Krech T, et al.Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection[J].Oncotarget, 2017, 8(52):89978-89987. [4] 胡秋博, 金悦, 李毓, 等.血浆游离DNA浓度与卵巢癌诊断及临床特征相关性的研究[J].实用妇产科杂志, 2018, 34(5):357-360. [5] Kim K, Shin DG, Park MK, et al.Circulating cell-free DNA as a promising biomarker in patients with gastric cancer:diagnostic validity and significant reduction of cfDNA after surgical resection[J].Ann Surg Treat Res, 2014, 86(3):136. [6] 刘永康. 采用改进的技术探究肝细胞癌循环肿瘤细胞的上皮间质化转变过程[D].广州:南方医科大学, 2017. [7] Saeed WK, Jun DW.Viewpoint:necroptosis influences the type of liver cancer via changes of hepatic microenvironment[J].Hepatobiliary Surg Nutr, 2019, 8(5):549-551. [8] 郭鸿雁, 刘庆峰.γ-谷氨酰转肽酶、高尔基体蛋白73及甲胎蛋白检测对早期原发性肝癌的诊断价值[J].癌症进展, 2019, 17(11):1332-1334. [9] Takeda K, Yamada T, Takahashi G, et al.Analysis of colorectal cancer-related mutations by liquid biopsy:Utility of circulating cell-free DNA and circulating tumor cells[J].Cancer Sci, 2019, 110(11):3497-3509. [10] Kalinich M, Bhan I, Kwan TT, et al.An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma[J].Proc Natl Acad Sci USA, 2017, 114(5):1123-1128. [11] 郭柏棠, 刘新城, 黄毓, 等.肝细胞癌患者外周血循环肿瘤细胞阳性提示预后不良[J].南方医科大学学报, 2016, 36(8):1134-1139. [12] Wan N, Weinberg D, Liu TY, et al.Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA[J].bioRxiv, 2018, DOI:10.1101/478065. [13] van Helden EJ, Angus L, Menke-van der Houven van Oordt C W, et al.RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer[J].Mol Oncol, 2019, 13(11):2361-2374. [14] 冉贵萍, 黄海, 杨国珍, 等.肝细胞癌患者血浆循环DNA的定量分析及临床意义[J].中国实验诊断学, 2015, 19(6):918-921. [15] Ramani VC, Lemaire CA, Triboulet M, et al.Investigat ing circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer[J].Breast Cancer Res, 2019, 21(1):1-16. [16] 万磊, 陈佳佳, 刘建军, 等.原发性肝癌患者CTCs与CD4~+/CD8~+、NLR、TTV及肿瘤分期的相关性研究[J].中国病理生理杂志, 2016, 32(6):1017-1021. [17] 王忠. 原发性肝癌患者外周血循环肿瘤细胞的EMT分型及临床意义[D].广州:南方医科大学, 2017. [18] Barták BK, Márkus E, Kalmár A, et al.Characteristics and diagnostic applications of circulating cell-free DNA in colorectal cancer[J].Orvosi Hetilap, 2019, 160(30):1167-1177. [19] 彭兰, 陈孝进, 王克仕, 等.肝癌患者血浆游离DNA检测的意义[J].中国实验诊断学, 2012, 16(2):308-310. [20] 刘忆华, 成善原, 李丽, 等.外周血循环肿瘤细胞在胰腺癌患者中的表达及临床病理诊断意义[J].河北医药, 2017, 39(10):1502-1503. |